New Optical Imaging System Could Be Deployed to Find Tiny Tumors
March 8, 2019 | MITEstimated reading time: 4 minutes
To demonstrate the potential usefulness of this system, the researchers tracked a 0.1-millimeter-sized cluster of fluorescent nanoparticles that was swallowed and then traveled through the digestive tract of a living mouse. These probes could be modified so that they target and fluorescently label specific cancer cells.
“In terms of practical applications, this technique would allow us to non-invasively track a 0.1-millimeter-sized fluorescently-labeled tumor, which is a cluster of about a few hundred cells. To our knowledge, no one has been able to do this previously using optical imaging techniques,” Bardhan says.
Earlier Detection
The researchers also demonstrated that they could inject fluorescent particles into the body of a mouse or a rat and then image through the entire animal, which requires imaging to a depth of about 4 centimeters, to determine where the particles ended up. And in tests with human tissue-mimics and animal tissue, they were able to locate the probes to a depth of up to 8 centimeters, depending on the type of tissue.
Guosong Hong, an assistant professor of materials science and engineering at Stanford University, described the new method as “game-changing.”
“This is really amazing work,” says Hong, who was not involved in the research. “For the first time, fluorescent imaging has approached the penetration depth of CT and MRI, while preserving its naturally high resolution, making it suitable to scan the entire human body.”
This kind of system could be used with any fluorescent probe that emits light in the near-infrared spectrum, including some that are already FDA-approved, the researchers say. The researchers are also working on adapting the imaging system so that it could reveal intrinsic differences in tissue contrast, including signatures of tumor cells, without any kind of fluorescent label.
In ongoing work, they are using a related version of this imaging system to try to detect ovarian tumors at an early stage. Ovarian cancer is usually diagnosed very late because there is no easy way to detect it when the tumors are still small.
“Ovarian cancer is a terrible disease, and it gets diagnosed so late because the symptoms are so nondescript,” Belcher says. “We want a way to follow recurrence of the tumors, and eventually a way to find and follow early tumors when they first go down the path to cancer or metastasis. This is one of the first steps along the way in terms of developing this technology.
Page 2 of 2Suggested Items
PCB Market Size to Grow by $29.06B from 2024-2028
05/17/2024 | PRNewswireThe global printed circuit board (PCB) market size is estimated to grow by USD 29.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 6.6% during the forecast period.
Terran Orbital Joins the Mobile Satellite Services Association (MSSA)
05/16/2024 | BUSINESS WIRETerran Orbital Corporation, a global leader in satellite-based solutions primarily serving the aerospace and defense industries, announced its membership in the Mobile Satellite Services Association (MSSA).
Raytheon-Kongsberg System is Proving Itself – In Demos and In Combat
05/16/2024 | Raytheon TechnologiesOn a rocky island off the coast of Norway, Michael Sadlowski watched as a surface-to-air missile launcher pointed up into a dark nighttime sky.
Un-Jammable Quantum Tech Takes Flight to Boost UK’s Resilience Against Hostile Actors
05/13/2024 | BUSINESS WIREOSI Systems Receives Order for $9 Million to Provide Cargo and Vehicle Inspection Systems
05/13/2024 | BUSINESS WIREOSI Systems, Inc. announced that its Security division received an order from an international customer for approximately $9 million to provide the Company’s Eagle® M60 high energy mobile cargo and vehicle inspection systems including related service and support.